The global pharmaceutical analytical testing outsourcing market size was valued at USD 8.3 billion in 2023 and is projected to grow at a CAGR of 8.4% from 2024 to 2030.
Growth in the market can be attributed due to increasing focus toward safety, & quality; regulation, pricing benefits of outsourcing, and rising number of end use. Besides, increasing R&D investment is one of the critical sustainability strategies adopted by market players. As, not all companies have an infrastructure for analytical testing. Therefore, outsourcing these operations is a suitable option, which helps to save time and cost.
Gather more insights about the market drivers, restrains and growth of the Pharmaceutical Analytical Testing Outsourcing Market
Other factors, such as the changing regulations for in vivo and in vitro tests, are also expected to propel the growth of the market for pharmaceutical analytical testing outsourcing. Besides, high demand for quality generic drugs, analytical testing methods, improved the quality and transparency of the review & approval process, and encourage new drug R&D in line with global development is anticipated to fuel the market growth.
In addition, innovation or new product development is directly proportional to the demand for testing services due to pricing concerns, competitive pressures, and lead-time to market, companies are opting for outsourcing of testing services. Moreover, focus on customized care and technological advancements, which has resulted in rapid development of new products. Likewise, development of biosimilar, combination products, and other innovative medicines has fueled the demand for pharmaceutical analytical testing services.
Browse through Grand View Research's Medical Devices Industry Research Reports.
• The global pharmaceutical regulatory affairs market size was estimated at USD 8.84 billion in 2023 and is projected to grow at a CAGR of 7.16% from 2024 to 2030.
• The global pharmaceutical packaging market size was valued at USD 139.37 billion in 2023 and is expected to grow a compound annual growth rate (CAGR) of 9.7% from 2024 to 2030.
Pharmaceutical Analytical Testing Outsourcing Market Segmentation
Grand View Research has segmented the prebiotic ingredient market based on type, application, and region:
Type Outlook (Revenue, USD Million, 2017 - 2028)
• Inulin
• Oligosaccharide (MOS/GOS/FOS)
• Others
Applications Outlook (Revenue, USD Million, 2017 - 2028)
• Food & Beverage
• Dietary Supplements
• Others
Regional Outlook (Revenue, USD Million, 2017 - 2028)
• North America
• Europe
• Asia Pacific
• Central & South America
• Middle East & Africa
Key Companies & Market Share Insights
Companies' are focusing on innovating new types of prebiotic ingredients to meet the increasing demand. New players are entering the market owing to low market entry barriers and higher market potential. The increasing demand for prebiotic ingredients offers an opportunity for product development in the regions of high demand. Some of the prominent players in the global prebiotic ingredient market include:
• Beneo-Orafti SA
• Tereos Group
• Ingredion Inc.
• Cargill Inc.
• DowDuPont Inc
• Royal FrieslandCampina N.V.
• Kerry Group
• Cosucra-groupe Warcoing SA
• Sensus BV
Recent Developments
• In December 2023, Agno Pharma acquired Lubrizol Particle Sciences Inc. The acquisition encompasses the drug product formulation technology integral to Particle Sciences Inc. including the PA, Bethlehem development & manufacturing site.
• In November 2023, Eurofins acquired Quasfar supporting the pharmaceutical industry in Latin America, enhancing its capabilities in R&D, providing support in the early stages of pharmaceutical product development.
Order a free sample PDF of the Pharmaceutical Analytical Testing Outsourcing Market Intelligence Study, published by Grand View Research.
Comments
0 comment